Hospital Mater Dei S.A. (BVMF:MATD3)

Brazil · Delayed Price · Currency is BRL

5.79

-0.01 (-0.17%)

At close: Apr 28, 2026

21.13% (1Y)

Market Cap	1.92B
Revenue (ttm)	2.18B
Net Income (ttm)	110.51M
Shares Out	332.13M
EPS (ttm)	0.33
PE Ratio	17.60
Forward PE	11.31
Dividend	0.15 (2.60%)
Ex-Dividend Date	Dec 9, 2025

Volume	120,200
Average Volume	92,010
Open	5.85
Previous Close	5.80
Day's Range	5.67 - 5.85
52-Week Range	4.13 - 6.17
Beta	0.49
RSI	51.68
Earnings Date	May 7, 2026

About Hospital Mater Dei

Hospital Mater Dei S.A. operates hospitals in Brazil. It engages in data and artificial intelligence business. The company was incorporated in 1973 and is headquartered in Belo Horizonte, Brazil. Hospital Mater Dei S.A. is a subsidiary of JSS Empreendimentos e Administração LTDA. [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1973

Employees 3,500

Stock Exchange Brazil Stock Exchange

Ticker Symbol MATD3

Full Company Profile

Financial Performance

Financial Statements

News

Hospital Mater Dei Earnings Call Transcript: Q3 2025

Record Q3 2025 results with net revenue of BRL 570 million and EBITDA up 39% year-over-year, driven by higher average ticket, operational efficiency, and strong performance in oncology and key units. Leverage reduced to 1.8x, with robust cash generation and continued focus on margin expansion.

6 months ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q2 2025

Record Q2 2025 revenue and EBITDA were achieved through higher complexity procedures, operational efficiency, and disciplined cost control. Key units like Salvador and Nova Lima delivered strong growth, while leverage and cash flow improved, supporting further debt prepayment and expansion plans.

9 months ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q1 2025

Record net revenue and margin improvements were achieved, driven by operational efficiency, strong performance in Salvador and Nova Lima, and growth in non-bed revenues. Cash flow enabled share buybacks and an extraordinary dividend, while Fitch reaffirmed the positive rating.

1 year ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q4 2024

2024 saw revenue and occupancy growth despite sector challenges, with cost pressures from regulatory changes and a focus on operational efficiency. New hospital ramp-ups and partnerships are set to drive margin recovery and cash generation in 2025.

1 year ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q3 2024

A new hospital opening has driven positive operational results, while cost pressures from the Nursing Bill and NDI issues remain a challenge. Ongoing policy improvements and negotiations aim to enhance efficiency and financial performance.

1 year ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q2 2024

Revenue grew 8.3% over H2 2023, but Q2 margins fell due to lower complexity, seasonality, and the nursing bill. July and August showed strong recovery, with improved mix and growth in surgeries, while divestment of Porto Dias and new projects support future profitability.

1 year ago - Transcripts

Hospital Mater Dei Earnings Call Transcript: Q1 2024

2 years ago - Transcripts